Signaling pathways mediating β3-adrenergic receptor-induced production of interleukin-6 in adipocytes
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
The β3-adrenergic receptor (β3AR) is an essential regulator of metabolic and endocrine functions. A major cellular and clinically significant consequence of β3AR activation is the substantial elevation in interleukin-6 (IL-6) levels. Although the β3AR-dependent regulation of IL-6 expression is well established, the cellular pathways underlying this regulation have not been characterized. Using a novel method of homogenous reporters, we assessed the pattern of activation of 43 transcription factors in response to the specific β3AR agonist CL316243 in adipocytes, cells that exhibit the highest expression of β3ARs. We observed a unique and robust activation of the CRE-response element, suggesting that IL-6 transcription is regulated via the Gs-protein/cAMP/protein kinase A (PKA) but not nuclear factor kappa B (NF-κB) pathway. However, pretreatment of adipocytes with pharmacologic inhibitors of PKA pathway failed to block β3AR-mediated IL-6 up-regulation. Additionally, stimulation of adipocytes with the exchange protein directly activated by cAMP (Epac) agonist did not induce IL-6 expression. Instead, the β3AR-mediated transcription of IL-6 required activation of both the p38 and PKC pathways. Western blot analysis further showed that transcription factors CREB and ATF-2 but not ATF-1 were activated in a p38- and PKC-dependent manner. Collectively, our results suggest that while stimulation of the β3AR leads to a specific activation of CRE-dependent transcription, there are several independent cellular pathways that converge at the level of CRE-response element activation, and in the case of IL-6 this activation is mediated by p38 and PKC but not PKA pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Kern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883 · cited 2×
“Although a causal role of IL-6 in diabetes still needs to be clarified, IL-6 levels correlate with the degree of insulin resistance in human subjects (Bastard et al., 2002; Kern et al., 2001) and predict the development of type 2 diabetes (Hu et al., 2004; Thorand et al., 2007).”
BackgroundFenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583 · cited 2×
“NF-κB activity can be inhibited using either NEMO binding peptide (NBD), which binds to and inactivates IKKγ thereby blocking the phosphorylation and degradation of IκB (May et al., 2000; Yamaoka et al., 1998), or MG-132, a proteosome inhibitor (Fenteany et al., 1995; Myung et al., 2001).”
BackgroundMethodLiver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,538 · cited 1×
“Furthermore, experiments with hepatectomy and hepatic warm ischemia/reperfusion injury demonstrated that IL-6 is a critical component for hepatocyte proliferation and liver regeneration (Camargo et al., 1997; Cressman et al., 1996).”
BackgroundRelationship between Adipocyte Size and Adipokine Expression and Secretion
Skurk, T., Alberti-Huber, C., Herder, C., & Hauner, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1055 · Cited by 1,288 · cited 1×
“Additionally, the production of IL-6 is well documented in different adipose tissues and adipocyte models (Burysek and Houstek, 1997; Fain et al., 2004; Hoch et al., 2008; Mohamed-Ali et al., 2001; Path et al., 2001; Skurk et al., 2007; Vicennati et al., 2002).”
BackgroundVgontzas, A. N., Papanicolaou, D. A., Bixler, E. O., Kales, A., Tyson, K., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3950 · Cited by 974 · cited 3×
“Consistent with these reports, plasma IL-6 levels are markedly elevated in obese subjects (Vgontzas et al., 1997).”
BackgroundInflammatory Markers and Risk of Developing Type 2 Diabetes in Women
Hu, F. B., Meigs, J. B., Li, T. Y., Rifai, N., & Manson, J. E. (2004) · Diabetes · doi:10.2337/diabetes.53.3.693 · Cited by 788 · cited 2×
“Although a causal role of IL-6 in diabetes still needs to be clarified, IL-6 levels correlate with the degree of insulin resistance in human subjects (Bastard et al., 2002; Kern et al., 2001) and predict the development of type 2 diabetes (Hu et al., 2004; Thorand et al., 2007).”
BackgroundSubcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor- , in Vivo
Mohamed-Ali, V. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.12.4196 · Cited by 717
IL-6 signal transduction and its physiological roles: the signal orchestration model
Kamimura, D., Ishihara, K., & Hirano, T. (2003) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-003-0012-2 · Cited by 673
Zhou, D., Kusnecov, A. W., Shurin, M. R., DePaoli, M., & Rabin, B. S. (1993) · Endocrinology · doi:10.1210/endo.133.6.8243274 · Cited by 494
Cited by
Neuroinflammation and Central Sensitization in Chronic and Widespread Pain
Ji, R.-R., Nackley, A., Huh, Y., Terrando, N., & Maixner, W. (2018) · Anesthesiology · doi:10.1097/aln.0000000000002130 · Cited by 1,630
Self-citationCan Quantitative Sensory Testing Move Us Closer to Mechanism-Based Pain Management?
Cruz-Almeida, Y., & Fillingim, R. B. (2014) · Pain Medicine · doi:10.1111/pme.12230 · Cited by 302
The phenotypic and genetic signatures of common musculoskeletal pain conditions
Diatchenko, L., Fillingim, R. B., Smith, S. B., & Maixner, W. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.43 · Cited by 241
Self-citationSaturated fatty acids activate microglia via Toll-like receptor 4/NF-κB signalling
Wang, Z., Liu, D., Wang, F., Liu, S., Zhao, S., Ling, E.-A., & Hao, A. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511002868 · Cited by 239
“…other transcriptional factors may be involved in IL-6 production, for example, activating protein-1 (41) , cAMP-induced transcription factors such as cAMP-responsive element binding protein and CCAAT-enhancer box binding protein (42,43) , or signal transducer and activator of transcription (44) .”
Nie, Y., Ma, R. C., Chan, J. C. N., Xu, H., & Xu, G. (2012) · The FASEB Journal · doi:10.1096/fj.11-196782 · Cited by 53
Metadata
- Authors
- Tchivileva, I. E., Tan, K. S., Gambarian, M., Nackley, A. G., Medvedev, A. V., Romanov, S., Flood, P. M., Maixner, W., Makarov, S. S., & Diatchenko, L.
- Venue
- Molecular Immunology
- Publisher
- Elsevier BV
- Published
- 2009-07
- Volume
- 46
- Issue
- 11-12
- Pages
- 2256-2266
- ISSN
- 0161-5890 (ISSN-L)
- OpenAlex
- W1995470140
- Cited by
- 39
- References
- 15
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.